Biochemical analysis of plasma-soluble invariant chains and their complex formation with soluble HLA-DR

Tissue Antigens

Volumn 49, Issue 5, 1997, Pages 438-442

  Rebmann, V ^a   Dornmair, K ^b   Grosse Wilde, H ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

Alternative splicing product; Complex formation of sCD74; Invariant chain; Isoform of sCD74; sCD74; sHLA DR; Soluble HLA DR; Soluble invariant chain

Indexed keywords

EDETIC ACID; HLA DR ANTIGEN;

ALTERNATIVE RNA SPLICING; ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; HLA SYSTEM; HUMAN; HUMAN CELL; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL;

EID: 0030949973     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0039.1997.tb02776.x     Document Type: Article

References (22)

1. Germain RN, Margulies DH. The biochemistry and cell biology of antigen processing and presentation. Annu Rev Immunol 1993: 11: 403-50.
2. Nordeng TW, Bakke O. The biological role of invariant chain (Ii) in MHC class II antigen presentation. Immunol Lett 1994: 43: 47-55.
3. Cresswell P. Chemistry and functional role of the invariant chain. Curr Opin Immunol 1992: 4: 87-92.
4. Strubin M, Berte C, Mach B. Alternative splicing and alternative initiation of translation explain the four forms of the Ia antigen-associated invariant chain. EMBO J 1986. 5: 3483-88.
5. Roche P.A Marks MS, Cresswell P. Formation of a nine-subunit complex by HLA class II glycoproteins and the invariant chain. Nature 1991: 354: 392-94.
6. Kämpgen E, Koch N, Koch F et al. Class II major histocompatibility complex of murine dendritic cells: synthesis, sialylation of invariant chain, and antigen processing capacity are down regulated upon culture. Proc Natl Acad Sci U S A 1991: 88: 3014-18.
7. Neefjes J.J, Stollorz V, Peters PJ, Geuze HJ, Ploegh HL. The biosynthetic pathway of MHC class II but not class I molecules intersects the endocytic route. Cell 1990: 61: 707-18.
8. Odorizzi CG, Trobridge I.S, Xue L, Hopkins CR, Davis CD, Collawn JF. Sorting signals in the MHC class II invariant chain cytoplasmatic region determine trafficking to an endocytic processing compartment. J Cell Biol 1994: 126: 317-30.
9. Bijlmakers MJ, Benaroche P, Ploegh HL. Assembly of HLA-DR1 molecules translated in vitro: binding of peptide in the endoplasmatic reticulum precludes association with invariant chain. EMBO J 1994: 13: 2699-707.
10. Blum JS, Cresswell P. Role for intracellular proteases in the processing and transport of class II HLA antigens. Proc Natl Acad Sci U S A 1988: 91: 3975-79.
11. Neefjes JJ, Ploegh HL. Inhibition of endosomal proteolytic activity by leupeptin blocks surface expression of MHC class II molecules and their conversion to SDS resistance alpha beta heterodimers in endosomes. EMBO J 1992: 11: 411-6.
12. Newcomb J, Cresswell P. Structural analysis of proteolytic products of MHC class II-invariant chain complexes generated in vivo. J Immunol 1993: 151: 4153-8.
13. Amigorena S, Webster P, Drake J, Newcomb J, Cresswell P, Mellman I. Invariant chain cleavage and peptide loading in MHC class II vesicles. J Exp Med 1995: 181: 1729-41.
14. Denzin LK, Cresswell P. HLA-DM induces CLIP dissociation from MHC Class II alpha beta dimers and facilitates peptide loading. Cell 1995: 82: 155-65.
15. Wraight JC, van Endert P, Möller P et al. Human major histocompatibility complex class II invariant chain is expressed on the cell surface. J Biol Chem 1990: 265: 5787-92.
16. Roche PA, Teletski CL, Karp DR, Pinet V, Bakke O, Long EO. Stable surface expression of invariant chain prevents peptide presentation by HLA-DR. EMBO J 1992: 11: 2841-47.
17. Naujokas MF, Morin M, Anderson MS, Peterson M, Miller J. The chondroitin sulfate form of invariant chain can enhance stimulation of T cell responses through interaction with CD44. Cell 1993: 74: 257-68.
18. Jendro M, Goronzy JJ, Weyand CC. Structural and functional characterization of HLA-DR molecules circulating in the serum. Autoimmunity 1991: 8: 289-96.
19. Westhoff U, Thinnes FT, Götz H, Grosse-Wilde H. Quantitation of soluble HLA class II molecules by an enzyme-linked immunosorbent assay. Vox Sang 1991: 61: 106-10.
20. Stöckle J, Meinle E, Hahnel C et al. Refolding of human class II major histocompatibility complex molecules isolated from Escherichia coli. Assemble of peptide free heterodimers and increased refolding yield in the present of antigenic peptide. J Biol Chem 1994: 269: 29571-78.
21. Arunachalam B, Lamb CA, Cresswell P. Transport properties of free and MHC class II-associated oligomers containing different isoforms of human invariant chain. Int Immunol 1994: 6: 439-42.
22. Fineschi B, Arneson LS, Naujokas MF, Miller J. Proteolysis of major histocompatibility complex class II-associated invariant chain is regulated by alternatively spliced gene product, p41. Proc Natl Acad Sci U S A 1995: 92: 10257-62.